Universal Ibogaine Inc. announced a private placement to issue up to 80,000,000 common shares at a price of CAD 0.01 per share for the gross proceeds of CAD 800,000 on February 22, 2024. The transaction is subject to the approval by the TSXV. All securities issued under the offering will be subject to a four-month hold period as required by the rules of the TSXV and Canadian Securities Laws, as well as any required hold periods under US Securities Laws for US resident purchasers.